skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Join former FDA Investigations Branch Director Ricki Chase – now with Lachman Consultants – as she draws on her 16 years of agency experience to bring you the latest insights into FDA inspections, interactions and expectations.

Compliance 360 Podcast Survival Guide is brought to you by Medtech Insight

With Medtech Insight, you can access extensive coverage of global medtech news and insight. Grasp global trends and source information on the impact of technologies like diagnostic imaging, drug delivery, 3-D printing and more.



Podcast Lineup

February 6
Handling Difficult US FDA Investigators

February 13
Getting The Most Out Of Your Inspection:
Close-Out Meetings

February 20
Building Trust With US FDA:
Can It Be Done?

February 27
How To Better Manage Your Quality Data

March 6
Medical Device 483s:
US FDA’s Top 5 Observations

March 13
Don’t Do That!
How To Respond To FDA-483s

March 20
Factors Feeding Your Inspection Cycle:
A New Paradigm

March 27
Patient Influence On US FDA’s
Enforcement Strategy

As a subscriber, you’ll enjoy anytime, any-device access to the industry’s key thinkers and opinion leaders. Plus, you can connect with the commercial market developments and information you need for success.

Medtech Insight subscribers – simply log in to your account to listen to the podcast each week.

Not a subscriber? Get a free trial below.

Read also

  • Biomedtracker: follow the drug development process

    Biomedtracker 2018 Early Outlook Report

    What's on the horizon for pharma in 2018? Find out with Biomedtracker&rsquo;s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.<br />

    Topics Drug development landscape

  • Biomedtracker: follow the drug development process

    Accurate, Intuitive and Updated In Real Time

    03 Apr 2017

    Learn why pharmaceutical, biotech, and investment companies rely on BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.

  • Scrip: industry news and insights

    Hong Kong Takes On Nasdaq For China Biotech IPOs

    By Brian Yang

    <span style="color: #58595b; text-align: start; letter-spacing: normal;">Hong Kong is catching global attention as it plans to drastically change listing rules for biotech firms, potentially opening the way to both Chinese companies seeking public funding and international firms eyeing entry to China. A Shanghai biosimilars developer, among others, is now eyeing an offering.</span>

    Topics Policy and regulation


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: